Pediatric Neurology: Neurological Care for Children

Pediatric neurology is the medical subspecialty focused on diagnosing and treating disorders of the nervous system in infants, children, and adolescents. The developing brain and peripheral nervous system present distinct clinical challenges that differ substantially from adult neurological disease — making specialized training and age-calibrated diagnostic tools essential. This page covers the scope of the field, how pediatric neurologists approach evaluation and treatment, the most common conditions encountered, and the boundaries that guide referrals between general pediatrics, pediatric neurology, and related subspecialties.

Definition and scope

Pediatric neurology addresses neurological conditions arising from birth through late adolescence, typically defined as up to age 18, though some pediatric practices extend care into the early 20s for continuity in conditions like epilepsy. The subspecialty sits at the intersection of general pediatrics and adult neurology, drawing on both the developmental sciences and the full diagnostic toolkit of neurological medicine.

The American Board of Psychiatry and Neurology (ABPN) certifies physicians in both Neurology with Special Qualification in Child Neurology and Neurodevelopmental Disabilities, representing 2 distinct certification pathways (ABPN, Certification in Child Neurology). This distinction matters clinically: a child neurologist focuses on acute and chronic neurological disease, while a neurodevelopmental disabilities specialist emphasizes developmental trajectories, cognitive delays, and functional outcomes.

The nervous system undergoes its most rapid structural and functional maturation during the first 5 years of life — the period of highest vulnerability to injury, malformation, and genetic disruption. Conditions such as neural tube defects, perinatal hypoxic-ischemic encephalopathy, and early-onset epileptic encephalopathies are fundamentally pediatric problems with pathophysiology tied to developmental timing. Understanding the full landscape of neurological subspecialties clarifies where pediatric neurology fits within the broader taxonomy of the field.

How it works

A pediatric neurological evaluation begins with a detailed developmental history — a component that has no parallel in adult neurology. The clinician maps developmental milestones (gross motor, fine motor, language, social-adaptive) against population norms from tools such as the Denver Developmental Screening Test II or the Ages & Stages Questionnaires. Regression of previously acquired milestones is treated as a high-priority red flag requiring urgent workup.

The neurological examination in children is adapted by age. In neonates, the assessment relies on primitive reflexes (Moro, rooting, palmar grasp), tone, and cranial nerve function. In toddlers, direct observation during play supplements formal testing. By school age, the examination closely resembles an adult neurological examination, with modifications for cognitive baseline and cooperation.

Diagnostic workup follows a structured sequence:

Electroencephalography (EEG): The primary tool for seizure characterization; routine, ambulatory 24-hour, and video-EEG protocols are selected based on seizure frequency and semiology (American Clinical Neurophysiology Society guidelines).
MRI brain and spine: Preferred over CT to avoid ionizing radiation in pediatric populations; high-field 3T protocols are standard at academic centers.
Genetic and metabolic testing: Chromosomal microarray, epilepsy gene panels, and metabolic screening (plasma amino acids, urine organic acids) address the high proportion of genetic etiologies in childhood neurological disease.
Lumbar puncture: Used for suspected CNS infection, autoimmune encephalitis, and neurodegenerative conditions when cerebrospinal fluid biomarkers are diagnostically relevant.
Neuropsychological testing: Quantifies cognitive, behavioral, and academic impact — essential for conditions like epilepsy and traumatic brain injury.

Treatment frameworks are governed by age-based pharmacokinetic differences. Many antiseizure medications carry distinct pediatric dosing parameters approved by the FDA under the Pediatric Research Equity Act (PREA), which requires manufacturers to study drugs in pediatric populations when adult approval is sought for conditions affecting children (FDA PREA overview).

Common scenarios

The five most frequently encountered diagnostic categories in pediatric neurology practice are:

Epilepsy and seizure disorders: The most common pediatric neurological condition, affecting approximately 1 in 150 children in the United States (CDC, Epilepsy Fast Facts). Age-specific epilepsy syndromes — including infantile spasms (West syndrome), childhood absence epilepsy, and juvenile myoclonic epilepsy — require syndrome-directed treatment rather than generic antiseizure therapy.
Headache and migraine: Migraine affects an estimated 10% of school-age children and is the leading cause of recurrent headache in pediatric neurology clinics (American Migraine Foundation).
Neurodevelopmental disorders with neurological overlap: Autism spectrum disorder, ADHD, and intellectual disability frequently present alongside seizures, movement abnormalities, or sleep disorders requiring neurological co-management.
Cerebral palsy: A group of permanent motor disorders arising from non-progressive disturbances in the developing brain; diagnosis requires ruling out progressive or treatable causes.
Autoimmune and inflammatory neurological disease: Anti-NMDA receptor encephalitis and pediatric multiple sclerosis are increasingly recognized, with MS onset before age 18 accounting for approximately 3–5% of all MS cases (National MS Society).

The regulatory context for neurological care — including HIPAA protections for minor patients, state-level age-of-consent variations for specific diagnoses, and Medicaid Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) mandates — shapes how pediatric neurological services are delivered and reimbursed across the US health system.

Decision boundaries

Pediatric neurology operates within a set of referral and scope boundaries that distinguish it from adjacent specialties:

Pediatric neurology vs. child psychiatry: Behavioral and emotional symptoms are frequently neurological in origin (autoimmune encephalitis, frontal lobe epilepsy, Tourette syndrome) but are often triaged to psychiatry first. The presence of abnormal movements, seizure-like episodes, acute behavioral change, or EEG abnormality marks the boundary favoring neurological evaluation.

Pediatric neurology vs. pediatric neurosurgery: Medical management of epilepsy, tumor surveillance, and spinal cord conditions begins with neurology; surgical candidacy for drug-resistant epilepsy, hydrocephalus, or structural lesions requires formal neurosurgical co-evaluation. The two disciplines share care in epilepsy surgery programs and neuro-oncology teams. A detailed comparison of medical and surgical roles is covered under neurology vs. neurosurgery.

Pediatric neurology vs. general pediatrics: General pediatricians manage febrile seizures (the most common seizure type in children under age 5), single unprovoked seizures with normal imaging and EEG, and stable headache syndromes. Referral thresholds include: focal neurological deficits, developmental regression, complex epilepsy syndromes, or any finding requiring specialized diagnostics.

Transition of care: Adolescents with chronic neurological conditions — epilepsy, MS, muscular dystrophies — require structured transition to adult neurology. The Child Neurology Society and the American Academy of Neurology have issued joint guidance emphasizing that transition planning should begin no later than age 14 (Child Neurology Society, Transition Resources).

The main neurology resource index provides structured access to the full range of neurological conditions, diagnostic methods, and treatment modalities referenced throughout this page.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)